Vermont has the second lowest state fatality rate in the US (146.3 per 100K; Hawaii 112.7/100K). Mississippi (462.8/100K) and Oklahoma (458.8/100K) have the highest rates. The US average is 306.4/100K ...

Although the bivalent COVID-19 vaccine conferred moderate protection against symptomatic disease, hybrid immunity provided the strongest protection.

The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

COVID-19 vaccination in early pregnancy (≤20 weeks of gestation) is not associated with increased prevalence of major ...

As the world marks the fifth anniversary of the start of the coronavirus pandemic, one question has persisted: How many lives ...

The Vermont pandemic death total stands at 1,278 as of March 6, 2025, an increase of 2 from the previous week (the most ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

The Novavax's COVID vaccine was approved by the US Food and Drug Administration for people age 12 and older in August 2024. This places it alongside Moderna's and Pfizer-BioNTech's refreshed formulas.

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In ...

[What you need to know about the Moderna and Pfizer coronavirus vaccines] Researchers in the United States set an audacious goal in January last year to develop a coronavirus vaccine within 12 to ...